INM
INM
NASDAQ · Pharmaceuticals

Inmed Pharmaceuticals Inc

$15.56
+2.35 (+17.79%)
As of Nov 7, 2:57 AM ET ·
Analyst Consensus
Strong Sell
8
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 38%
Sell 5 63%
Price Target
Analyst Price Target +116.3% upside
Low Target $24.21
Average Target $33.65
High Target $46.15
Current Price $15.56
Current
$15.56
Target
$33.65
$24.21 $33.65 avg $46.15
Scenario Analysis
Bear Case
$24.21
55.6%
Low target
Base Case
$33.65
+116.3%
Avg target
Bull Case
$46.15
+196.6%
High target
Risk/Reward
3.5x
Highly favorable
Price in Context
52-Week High
$2.33
567.8% from high
52-Week Low
$0.58
+2,606.1% from low
Target vs 52W High
$33.65
+1,344.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%